These results suggest that the KCNQ2 encephalopathy patients with LOF mutation might potentially benefit from KCNQ opener, consistent with previous work by Nissenkorn et al. [41], in which a patient carrying a LOF benefited from the application of RTG. This evidence concerns the gene KCNQ2 and Encephalopathy.